David Y. Liu
David Y. Liu founded Trenovus, Inc. Currently, he is Chief Scientific Officer, Head-R&D at Protagonist Therapeutics, Inc.
He previously was Chief Operating Officer of Trenovus, Inc., Vice President-Research at FibroGen, Inc., Director-Inflammation Research at Scios, Inc. and Assistant Professor-Medicine Department at Harvard Medical School.
Dr. Liu received a doctorate from Michigan State University and an undergraduate degree from The University of Chicago.
Transactions
Date
Transaction
Value
| 02/28/2022 | 2,119 | Derivative/Non-derivative trans. at $24.28 per share. | 51,450 |
| 02/15/2022 | 10,000 | Award at $0 per share. | 0 |
| 08/17/2021 | 14,779 | Disposition at $47.56 per share. | 702,890 |
| 08/17/2021 | 10,000 | Derivative/Non-derivative trans. at $0.87 per share. | 8,700 |
| 02/26/2021 | 10,000 | Award at $0 per share. | 0 |
| 08/06/2019 | 3,395 | Disposition at $8.85 per share. | 30,046 |
| 03/01/2019 | 810 | Disposition at $8.03 per share. | 6,505 |
| 02/28/2019 | 15,000 | Award at $0 per share. | 0 |
| 02/06/2019 | 3,821 | Disposition at $7.74 per share. | 29,575 |
| 08/15/2018 | 25,800 | Award at $0 per share. | 0 |
| 03/12/2018 | 3,500 | Disposition at $21.29 per share. | 74,515 |
| 03/12/2018 | 3,500 | Derivative/Non-derivative trans. at $4.21 per share. | 14,735 |
| 03/02/2018 | 875 | Disposition at $20 per share. | 17,500 |
| 03/02/2018 | 875 | Derivative/Non-derivative trans. at $1.89 per share. | 1,653 |
| 02/28/2018 | 9,500 | Award at $0 per share. | 0 |
| 01/16/2018 | 875 | Disposition at $20 per share. | 17,500 |
| 01/16/2018 | 875 | Derivative/Non-derivative trans. at $1.89 per share. | 1,653 |
| 12/18/2017 | 875 | Disposition at $20 per share. | 17,500 |
| 12/18/2017 | 875 | Derivative/Non-derivative trans. at $1.89 per share. | 1,653 |
| 11/30/2017 | 875 | Disposition at $20 per share. | 17,500 |
| 11/30/2017 | 875 | Award at $1.89 per share. | 1,653 |
| 11/13/2017 | 3,500 | Disposition at $16.97 per share. | 59,395 |
| 11/13/2017 | 3,500 | Derivative/Non-derivative trans. at $1.89 per share. | 6,615 |
| 11/13/2017 | 3,500 | Disposition at $16.97 per share. | 59,395 |
| 11/13/2017 | 3,500 | Derivative/Non-derivative trans. at $4.21 per share. | 14,735 |
| 08/28/2017 | 3,500 | Disposition at $15 per share. | 52,500 |
| 08/28/2017 | 3,500 | Derivative/Non-derivative trans. at $4.21 per share. | 14,735 |
| 07/10/2017 | 3,500 | Disposition at $12.68 per share. | 44,380 |
| 07/10/2017 | 3,500 | Derivative/Non-derivative trans. at $1.89 per share. | 6,615 |
